Quest Diagnostics Statistics

Total Valuation

Quest Diagnostics has a market cap or net worth of GBP 13.73 billion. The enterprise value is 18.86 billion.

Market Cap	13.73B
Enterprise Value	18.86B

Important Dates

The next estimated earnings date is Friday, January 31, 2025.

Earnings Date	Jan 31, 2025
Ex-Dividend Date	Jan 14, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-2.41%
Shares Change (QoQ)	+0.89%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	111.12M

Valuation Ratios

The trailing PE ratio is 21.96.

PE Ratio	21.96
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.63, with an EV/FCF ratio of 24.71.

EV / Earnings	30.17
EV / Sales	2.44
EV / EBITDA	10.63
EV / EBIT	17.08
EV / FCF	24.71

Financial Position

The company has a current ratio of 1.25, with a Debt / Equity ratio of 1.01.

Current Ratio	1.25
Quick Ratio	1.02
Debt / Equity	1.01
Debt / EBITDA	3.22
Debt / FCF	6.81
Interest Coverage	6.69

Financial Efficiency

Return on equity (ROE) is 13.22% and return on invested capital (ROIC) is 6.60%.

Return on Equity (ROE)	13.22%
Return on Assets (ROA)	5.65%
Return on Capital (ROIC)	6.60%
Revenue Per Employee	161,751
Profits Per Employee	14,210
Employee Count	48,000
Asset Turnover	0.65
Inventory Turnover	34.75

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +16.00% in the last 52 weeks. The beta is 0.89, so Quest Diagnostics's price volatility has been lower than the market average.

Beta (5Y)	0.89
52-Week Price Change	+16.00%
50-Day Moving Average	156.45
200-Day Moving Average	147.91
Relative Strength Index (RSI)	45.70
Average Volume (20 Days)	189

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.47

Income Statement

In the last 12 months, Quest Diagnostics had revenue of GBP 7.12 billion and earned 625.23 million in profits. Earnings per share was 5.55.

Revenue	7.12B
Gross Profit	2.35B
Operating Income	998.28M
Pretax Income	846.82M
Net Income	625.23M
EBITDA	1.35B
EBIT	998.28M
Earnings Per Share (EPS)	5.55

Full Income Statement

Balance Sheet

The company has 570.02 million in cash and 5.20 billion in debt, giving a net cash position of -4.63 billion.

Cash & Cash Equivalents	570.02M
Total Debt	5.20B
Net Cash	-4.63B
Net Cash Per Share	n/a
Equity (Book Value)	5.16B
Book Value Per Share	45.36
Working Capital	396.18M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.04 billion and capital expenditures -279.04 million, giving a free cash flow of 763.26 million.

Operating Cash Flow	1.04B
Capital Expenditures	-279.04M
Free Cash Flow	763.26M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 32.97%, with operating and profit margins of 14.03% and 8.82%.

Gross Margin	32.97%
Operating Margin	14.03%
Pretax Margin	11.90%
Profit Margin	8.82%
EBITDA Margin	18.92%
EBIT Margin	14.03%
FCF Margin	10.72%

Dividends & Yields

This stock pays an annual dividend of 2.37, which amounts to a dividend yield of 1.56%.

Dividend Per Share	2.37
Dividend Yield	1.56%
Dividend Growth (YoY)	4.31%
Years of Dividend Growth	7
Payout Ratio	38.88%
Buyback Yield	2.41%
Shareholder Yield	3.97%
Earnings Yield	4.55%
FCF Yield	5.56%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Quest Diagnostics has an Altman Z-Score of 2.71. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.71
Piotroski F-Score	n/a